IIQ
INOVIQ LTD ORDINARYINOVIQ Ltd develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. It offers hTERT ICC test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET, an EV isolation tool for biomarker discovery and diagnostic development. It offers non-invasive, diagnostics using its proprietary exosome develops technologies for improved screening, diagnosis, treatment selection and monitoring of cancer and other diseases. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was founded in 2016 and is headquartered in Notting Hill, Australia.
IIQ
IIQ
INOVIQ LTD ORDINARY
INOVIQ Ltd develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. It offers hTERT ICC test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET, an EV isolation tool for biomarker discovery and diagnostic development.
Fundamentals
Historical Data10 days
| Date | Short % | Gross Short |
|---|---|---|
| 16 July | — | — |
| 15 July | — | — |
| 14 July | — | — |
| 13 July | 0.00% | — |
| 10 July | 0.00% | — |
| 9 July | 0.00% | — |
| 8 July | 0.00% | — |
| 7 July | 0.00% | — |
| 6 July | 0.00% | — |
| 3 July | 0.00% | — |
Inoviq LTD (IIQ) Short Interest Summary
Inoviq LTD (IIQ) currently has 0.00% of its shares sold short (0 thousand shares, worth approximately $0K), based on ASIC short position data reported on 13 July 2026 (T+4 reporting lag). That makes IIQ the #724 most shorted stock on the ASX most shorted list. Short interest in IIQ is up 0.00% over the past week. IIQ is part of the Health Care sector on the ASX.
Recent IIQ Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 13 July 2026 | 0.00% | 0.0M | $0.22 |
| 10 July 2026 | 0.00% | 0.0M | $0.22 |
| 9 July 2026 | 0.00% | 0.0M | $0.23 |
| 8 July 2026 | 0.00% | 0.0M | $0.22 |
| 7 July 2026 | 0.00% | 0.0M | $0.24 |
| 6 July 2026 | 0.00% | 0.0M | $0.24 |
| 3 July 2026 | 0.00% | 0.0M | $0.25 |
IIQ Short Selling — Frequently Asked Questions
What is Inoviq LTD (IIQ)'s current short interest?
Inoviq LTD (IIQ) currently has a short interest of 0.00% of total shares outstanding. This means 0.00% of IIQ's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is IIQ heavily shorted on the ASX?
IIQ has a relatively low short interest of 0.00%. Short interest below 5% generally suggests limited bearish sentiment from short sellers.
What does short interest mean for IIQ investors?
Short interest in IIQ shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 0.00%, IIQ's short interest is at a low level. See our short squeeze candidates and days to cover analysis for more context.
Where does this IIQ short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for IIQ.